Results

Total Results: 3,558 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

2801. Geographic Variation in Potentially Preventable Hospitalizations for Acute and Chronic Conditions, 2005-2011 (pdf file)
      hcup-us.ahrq.gov/reports/statbriefs/sb178-Preventable-Hospitalizations-by-Region.pdf
      September 01, 2014 - worsening chronic conditions that might have been avoided with the delivery of high-quality outpatient treatment … Rates of hospitalization for chronic PQIs were based on admissions for diabetes, angina, congestive … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or chemical … quality of health services, medical practice patterns, access to health care programs, and outcomes of treatments

2802. Nis 2006 Maskedstats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
      January 01, 2006 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 11751 0.15 772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 761 0.01 2950: DIABETES WO CC 28347 0.35 2951: DIABETES W CC 34118 0.42 2952: DIABETES … WO CC 5871 0.07 4521: COMPLICATIONS OF TREATMENT W CC 9265 0.11 4522: COMPLICATIONS OF TREATMENT W … insipidus 436 0.01 END04: Diabetes Mellitus Type 1 32283 0.40 END05: Diabetes Mellitus Type 2 and … 1366 0.02 OTH85: Encounter for Preventive Health Services 2346 0.03 OTH86: Encounter for Radiation Therapy

2803. Nis 2003 Summarystats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
      January 01, 2003 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 8234 0.10 772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 597 0.01 2950: DIABETES W/O CC 28252 0.35 2951: DIABETES W CC 29178 0.37 2952: DIABETES … W/O CC 5950 0.07 4521: COMPLICATIONS OF TREATMENT W CC 7759 0.10 4522: COMPLICATIONS OF TREATMENT … insipidus 308 0.00 END04: Diabetes Mellitus Type 1 43646 0.55 END05: Diabetes Mellitus Type 2 and … 1415 0.02 OTH85: Encounter for Preventive Health Services 5442 0.07 OTH86: Encounter for Radiation Therapy

2804. Nis 2005 Summarystats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
      January 01, 2005 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 9211 0.12 772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 727 0.01 2950: DIABETES WO CC 28660 0.36 2951: DIABETES W CC 31430 0.39 2952: DIABETES … WO CC 5878 0.07 4521: COMPLICATIONS OF TREATMENT W CC 8624 0.11 4522: COMPLICATIONS OF TREATMENT W … insipidus 432 0.01 END04: Diabetes Mellitus Type 1 33412 0.42 END05: Diabetes Mellitus Type 2 and … 1536 0.02 OTH85: Encounter for Preventive Health Services 2881 0.04 OTH86: Encounter for Radiation Therapy

2805. Nis 2004 Summarystats Severity (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
      January 01, 2004 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 11147 0.14 772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 672 0.01 2950: DIABETES W/O CC 28740 0.36 2951: DIABETES W CC 31070 0.39 2952: DIABETES … W/O CC 5977 0.07 4521: COMPLICATIONS OF TREATMENT W CC 8557 0.11 4522: COMPLICATIONS OF TREATMENT … insipidus 321 0.00 END04: Diabetes Mellitus Type 1 44455 0.56 END05: Diabetes Mellitus Type 2 and … of Total OTH85: Encounter for Preventive Health Services 7994 0.10 OTH86: Encounter for Radiation Therapy

2806. Microsoft PowerPoint - Spotlight Case_Gabapentin Overdose_12.21.2022 FINAL.pptx (pdf file)
      psnet.ahrq.gov/sites/default/files/2023-01/spotlight_overdose_of_gabapentin_and_oxycodone_in_a_patient_with_end-stage_renal_disease.pdf
      January 01, 2023 - Details (1) • A 38-year-old man with end-stage renal disease (ESRD) on chronic hemodialysis, type 2 diabetes … • Oxycodone is considered a second-line therapy compared with other opioids and may be used with … including baclofen, tizanidine, cyclobenzaprine, and methocarbamol, are commonly used as adjunctive treatments … patient- specific information, usually at the point of care, to help inform decisions about a patient's treatment … Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled

2807. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
      August 12, 2016 - The authors might also note that there have been remarkable changes in outcome measurements and treatment … that further attention might be given to the potential secular influences of outcome assessment and treatment … Major CVD risk factors can also consider diabetes. … Diabetes was considered as an at-risk population. … But diabetes is not a CVD outcome, nor was it considered to be a standard CVD intermediate outcome

2808. Introduction | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/tint.html
      October 01, 2014 - asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and diabetes

2809. Nis 1999 Summarystats Core10A (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
      January 01, 1999 - PROC W/O CC 30 0.00 294: DIABETES AGE >35 4004 0.56 295: DIABETES AGE 0-35 1651 0.23 296: NUTRITIONAL … W CC 965 0.13 453: COMPLICATIONS OF TREATMENT W/O CC 386 0.05 454: OTHER INJURY, POISONING & TOXIC … mellitus without complication 320 0.04 50: Diabetes mellitus with complications 8778 1.22 51: Other … 1102 0.15 146: Treatment, fracture or dislocation of hip and femur 5505 0.76 147: Treatment, fracture … radiology 1355 0.19 212: Diagnostic physical therapy 169 0.02 213: Physical therapy exercises, manipulation

2810. Nis 1999 Summarystats (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
      January 01, 1999 - PROC W/O CC 290 0.00 294: DIABETES AGE >35 39092 0.54 295: DIABETES AGE 0-35 16305 0.23 296: NUTRITIONAL … 4525 0.06 437: ALC/DRUG DEPENDENCE, COMBINED REHAB & DETOX THERAPY 9252 0.13 439: SKIN GRAFTS FOR … mellitus without complication 3054 0.04 50: Diabetes mellitus with complications 87439 1.21 51: Other … 10732 0.15 146: Treatment, fracture or dislocation of hip and femur 55242 0.77 147: Treatment, fracture … radiology 13437 0.19 212: Diagnostic physical therapy 1608 0.02 213: Physical therapy exercises, manipulation

2811. Nis 1998 Summarystats (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
      January 01, 1998 - PROC W/O CC 257 0.00 294: DIABETES AGE >35 37543 0.55 295: DIABETES AGE 0-35 14847 0.22 296: NUTRITIONAL … 4874 0.07 437: ALC/DRUG DEPENDENCE, COMBINED REHAB & DETOX THERAPY 9756 0.14 439: SKIN GRAFTS FOR … mellitus without complication 2173 0.03 50: Diabetes mellitus with complications 83770 1.23 51: Other … 10819 0.16 146: Treatment, fracture or dislocation of hip and femur 54600 0.80 147: Treatment, fracture … radiology 13792 0.20 212: Diagnostic physical therapy 1022 0.01 213: Physical therapy exercises, manipulation

2812. Nis 1999 Summarystats Core10B (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10B.PDF
      January 01, 1999 - PROC W/O CC 30 0.00 294: DIABETES AGE >35 3975 0.55 295: DIABETES AGE 0-35 1555 0.22 296: NUTRITIONAL … W CC 943 0.13 453: COMPLICATIONS OF TREATMENT W/O CC 414 0.06 454: OTHER INJURY, POISONING & TOXIC … mellitus without complication 331 0.05 50: Diabetes mellitus with complications 8680 1.21 51: Other … 1042 0.14 146: Treatment, fracture or dislocation of hip and femur 5563 0.77 147: Treatment, fracture … radiology 1377 0.19 212: Diagnostic physical therapy 171 0.02 213: Physical therapy exercises, manipulation

2813. Nis 1998 Summarystats Core10B (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
      January 01, 1998 - PROC W/O CC 30 0.00 294: DIABETES AGE >35 3829 0.56 295: DIABETES AGE 0-35 1448 0.21 296: NUTRITIONAL … W CC 873 0.13 453: COMPLICATIONS OF TREATMENT W/O CC 334 0.05 454: OTHER INJURY, POISONING & TOXIC … mellitus without complication 218 0.03 50: Diabetes mellitus with complications 8414 1.23 51: Other … 1100 0.16 146: Treatment, fracture or dislocation of hip and femur 5457 0.80 147: Treatment, fracture … radiology 1398 0.20 212: Diagnostic physical therapy 113 0.02 213: Physical therapy exercises, manipulation

2814. Nis 1998 Summarystats Core10A (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
      January 01, 1998 - PROC W/O CC 27 0.00 294: DIABETES AGE >35 3733 0.55 295: DIABETES AGE 0-35 1505 0.22 296: NUTRITIONAL … W CC 845 0.12 453: COMPLICATIONS OF TREATMENT W/O CC 343 0.05 454: OTHER INJURY, POISONING & TOXIC … mellitus without complication 209 0.03 50: Diabetes mellitus with complications 8310 1.22 51: Other … 1061 0.16 146: Treatment, fracture or dislocation of hip and femur 5546 0.81 147: Treatment, fracture … radiology 1379 0.20 212: Diagnostic physical therapy 102 0.01 213: Physical therapy exercises, manipulation

2815. Synthesizing Lessons Learned Using Health Information Technology - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/r03hs018830-nemeth-final-report-2013.pdf
      January 01, 2013 - Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical … (CRC screening) NCI • MS-TRIP (medication safety) AHRQ • SO-TRIP (screening, immunizations and diabetes … practices had made in their participation in improving performance on alcohol screening, intervention and treatment … posters, screening/immunizatio n events • Press releases • Brief intervention, counseling, treatment

2816. Integrating Patient-Reported Outcomes into Practice: Benefits, Challenges, and Recommendations for Action (pdf file)
      digital.ahrq.gov/sites/default/files/docs/integrating-pros-into-practice-slides-02272024.pdf
      February 27, 2024 - joints and lead to disability if untreated • RA impacts ~1% of Americans • The main goals of RA treatment … Stable with current treatment. She rates her SDAI 7/10, but that is [...] … shown that treating to a target of low disease activity or remission in RA improves outcomes; this treatment … approach requires the use of standardized measures to define the treatment target (see Figure). … focused on patients aged 50+ (expanded to 18+ in scaled implementation) using oral medications for diabetes

2817. 1. Which patients benefit the most from MTM services? 1.1. Which factors, or combinations of factors, are most predictive of the clinical benefit of MTM services? 1.1.1. Disease factors (e.g., diabetes vs COPD ; multi-morbidity vs single… | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-di

2818. Methods Research Report: Improving Health Systems' Access to High-Quality Evidence: AHRQ EPC 2018 Pilot Projects Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-improving-health-systems-access.pdf
      August 01, 2019 - Interactive Presentation of EPC Reports and Mapping to Quality Measures “Protocol for Nonsurgical Treatments … Measure Codes on the Perceived Value of EPC Reports to Health-Systems “Protocol for Nonsurgical Treatments … Web-based Presentation and Discussion of Evidence “Screening for Abnormal Glucose and Type 2 Diabetes … information about desired comparisons and outcomes Support system-wide implementation of a therapy … “Individuals noted that the [treatments] in the dissemination products are not used in their department

2819. 10th Annual Report to Congress on High-Priority Evidence Gaps (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
      November 01, 2020 - Evaluate screening for major depressive disorder in children age 11 years or younger • Evaluate combined treatments … might be effective in individuals at average or high risk, so we can understand whether tailored therapies … depressive disorder in children age 11 years or younger • Evaluate the benefits and harms of combined treatments … individuals, such as American Indians and Hispanic/Latino adolescents, so we can determine whether tailored therapies … in Adolescents & Adults Screening for Impaired Visual Acuity & Glaucoma Screening for Type 2 Diabetes

2820. A National Web Conference on Evaluation of Personal Health Record (PHR) Systems and their Impact on Chronic Disease (pdf file)
      digital.ahrq.gov/sites/default/files/docs/phr-impact-chronic-disease-transcript-012512.pdf
      August 01, 2012 - CPAP is the main treatment, and the gold treatment, for sleep apnea. … It stands for continuous positive airway pressure therapy. … providing extra education, interventions that are specific to providing clinical support, providing therapeutic … , or self-management therapy. … Was diabetes considered? PEGGY WAGNER: Diabetes was considered.